Drug intelligence / Profile preview

N-[(2',4'-difluoro-4-hydroxy-5-iodobiphenyl-3-yl)carbonyl]-beta-alanine

Development stage
Unknown
Modality
Small Molecules
01

Overview

N‑[(2′,4′‑Difluoro‑4‑hydroxy‑5‑iodobiphenyl‑3‑yl)carbonyl]‑beta-alanine is an experimental small molecule compound belonging to the biphenyl derivatives class. It has a molecular formula of C16H12F2INO4 and a molecular weight of approximately 447.17 g/mol[1][6][7]. The compound is not approved for any clinical use and there are no known indications or associated conditions in regulatory databases or clinical trial registries[6]. Its mechanism of action, biological targets, pharmacological activity, and therapeutic potential have not been described in publicly available sources as of June 2025.

Other names
3-{[5-(2,4-difluorophenyl)-2-hydroxy-3-iodophenyl]formamido}propanoic acidN-[2',4'-difluoro-4-hydroxy–5–iodobiphenyl–3–yl]carbonyl-beta-alanine
02

Targets

TTR (Transthyretin)

Beyond the preview

Go deeper on N-[(2',4'-difluoro-4-hydroxy-5-iodobiphenyl-3-yl)carbonyl]-beta-alanine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on N-[(2',4'-difluoro-4-hydroxy-5-iodobiphenyl-3-yl)carbonyl]-beta-alanine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call